Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This protocol outlines a Cochrane Review designed to evaluate the efficacy and safety of the levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study 2013
- Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials 2015
- Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding. 2000
Cited by (1)
References (20)
- Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding. via openalex
- Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials via openalex
- LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study via openalex
- W1966716045 via openalex
- W2010208644 via openalex
- W2024827041 via openalex
- W2027516911 via openalex
- W2044060855 via openalex
- W2095881173 via openalex
- W2097113048 via openalex
- W2107942005 via openalex
- W2125950103 via openalex
- W2128116196 via openalex
- W2168590403 via openalex
- W2252630071 via openalex
- W3022034961 via openalex
- W1516966873 via openalex
- W3142150957 via openalex
- W1525668142 via openalex
- W1544704652 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK